REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy

Projektinformationen

RESPINE

ID Finanzhilfevereinbarung: 732163

DOI

10.3030/732163

Projekt abgeschlossen

EK-Unterschriftsdatum 9 Dezember 2016

Startdatum 1 Januar 2017

Enddatum 30 Juni 2023

Finanziert unter

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Gesamtkosten

€ 5 555 836,25

EU-Beitrag

€ 5 555 836,25

Koordiniert durch

CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER
France

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (9)

RESPINE final clinical trial report
Report describing the role of miRNAs in regulating the immunosuppressive capacity of human MSCs
Midterm recruitment report
Dissemination and Communication

CHUM will be prepared logo, poster, video, brochure and website

Report describing the profile of inflammatory markers and cytokine meditators that contribute to the inflammatory nature of the degenerated disc
Registration of clinical trial on EudraCT and Clinicaltrials.gov

Registration of clinical trial on EudraCT and Clinicaltrials.gov. Transfer the register number to the european comission

Report describing the identification of inflammatory mediators capable of “licensing”: MSCs in vitro
Minutes of the Meeting with complementary projects

A Meeting with representatives from these and any other complementary projects will be set-up in M24 to discuss and exchange best-practices regarding scientific, standardisation, economic and regulatory issues related to projects’ results. Networking and exchange of best practices with similar initiatives will also take place throughout the project at conferences and other events.

"Report describing the functional effects of ""licensed"" allogeneic MSCs on the activation of T cells and macrophages in vitro"

Report describing the functional effects of licensed allogeneic MSCs on the activation of T cells and macrophages in vitro

Websites, patent fillings, videos etc. (2)

RESPINE final workshop

RESPINE workshops will be organized the final workshop in M78 by CHUM The target audience will include scientists clinicians pathologists members of standards working groups patient groups future potential partners investors students and regulators

RESPINE midterm workshop

RESPINE workshops will be organized at M24 by UCBMThe target audience will include scientists clinicians pathologists members of standards working groups patient groups future potential partners investors students and regulators The RESPINE clinical study its evaluation and impacts will be presented along with the database

Veröffentlichungen

Peer reviewed articles (6)

Mesenchymal Stem Cell-Derived Exosomes: The New Frontier for the Treatment of Intervertebral Disc Degeneration

Autoren: Veronica Tilotta, Gianluca Vadalà ,Luca Ambrosio, Fabrizio Russo, Claudia Cicione, Giuseppina Di Giacomo, Rocco Papalia andVincenzo Denaro
Veröffentlicht in: Applied Sciences, 2021, ISSN 2076-3417
Herausgeber: MDPI
DOI: 10.3390/app112311222

miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells

Autoren: Yves-Marie Pers, Claire Bony, Isabelle Duroux-Richard, Laurène Bernard, Marie Maumus, Said Assou, Frank Barry, Christian Jorgensen, Danièle Noël
Veröffentlicht in: Frontiers in Immunology, Ausgabe 12, 2021, ISSN 1664-3224
Herausgeber: frontiersin
DOI: 10.3389/fimmu.2021.624024

Mesenchymal Stromal Cell-Derived Extracellular Vesicles Regulate the Mitochondrial Metabolism via Transfer of miRNAs

Autoren: Claire Loussouarn, Yves-Marie Pers, Claire Bony, Christian Jorgensen, Danièle Noël
Veröffentlicht in: Frontiers in Immunology, Ausgabe 12, 2021, ISSN 1664-3224
Herausgeber: frontiersin
DOI: 10.3389/fimmu.2021.623973

Combinatorial conditioning of adipose derived‐mesenchymal stem cells enhances their neurovascular potential: Implications for intervertebral disc degeneration

Autoren: Abbie. L. A. Binch, Stephen M. Richardson, Judith A. Hoyland, Frank P. Barry
Veröffentlicht in: JOR SPINE, Ausgabe 2/4, 2019, ISSN 2572-1143
Herausgeber: JOR SPINE
DOI: 10.1002/jsp2.1072

Allogenic bone marrow–derived mesenchymal stromal cell–based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study)

Autoren: Yves-Marie Pers, Robert Soler-Rich, Gianluca Vadalà, Rosanna Ferreira, Claire Duflos, Marie-Christine Picot, Fanchon Herman, Sylvie Broussous, Ana Sánchez, David Noriega, Francisco Ardura, Mercedes Alberca Zaballos, Verónica García, Virginia Gordillo Cano, Margarita González-Vallinas, Vicenzo Denaro, Fabrizio Russo, Jérôme Guicheux, Joan Vilanova, Lluís Orozco, Hans-Jörg Meisel, Matias Al
Veröffentlicht in: Annals of the Rheumatic Diseases, Ausgabe 83, 2025, Seite(n) 1572-1583, ISSN 0003-4967
Herausgeber: BMJ Publishing Group
DOI: 10.1136/ard-2024-225771

A Hyaluronan and Platelet-Rich Plasma Hydrogel for Mesenchymal Stem Cell Delivery in the Intervertebral Disc: An Organ Culture Study

Autoren: Fabrizio Russo, Luca Ambrosio, Marianna Peroglio, Wei Guo, Sebastian Wangler, Jan Gewiess, Sibylle Grad, Mauro Alini, Rocco Papalia, Gianluca Vadalà, Vincenzo Denaro
Veröffentlicht in: International Journal of Molecular Sciences, Ausgabe 22/6, 2021, Seite(n) 2963, ISSN 1422-0067
Herausgeber: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22062963